A detailed history of Manufacturers Life Insurance Company, The transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 142,040 shares of ARWR stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142,040
Previous 149,156 4.77%
Holding current value
$2.99 Million
Previous $3.88 Million 29.08%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$19.36 - $29.54 $137,765 - $210,206
-7,116 Reduced 4.77%
142,040 $2.75 Million
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $36,675 - $47,358
1,677 Added 1.14%
149,156 $3.88 Million
Q1 2024

May 14, 2024

BUY
$27.21 - $39.48 $567,083 - $822,802
20,841 Added 16.46%
147,479 $4.22 Million
Q4 2023

Feb 13, 2024

SELL
$21.2 - $31.03 $68,878 - $100,816
-3,249 Reduced 2.5%
126,638 $3.88 Million
Q3 2023

Nov 15, 2023

BUY
$26.2 - $36.08 $315,814 - $434,908
12,054 Added 10.23%
129,887 $3.49 Million
Q2 2023

Aug 11, 2023

SELL
$25.16 - $41.38 $142,154 - $233,797
-5,650 Reduced 4.58%
117,833 $4.2 Million
Q1 2023

May 15, 2023

SELL
$23.68 - $38.51 $34,359 - $55,878
-1,451 Reduced 1.18%
122,032 $3.1 Million
Q4 2022

Aug 11, 2023

SELL
$28.0 - $40.56 $11,004 - $15,940
-393 Reduced 0.32%
123,483 $5.01 Million
Q4 2022

Feb 13, 2023

SELL
$28.0 - $40.56 $11,004 - $15,940
-393 Reduced 0.32%
123,483 $5.01 Million
Q3 2022

Aug 11, 2023

SELL
$29.63 - $48.31 $103,290 - $168,408
-3,486 Reduced 2.74%
123,876 $4.09 Million
Q3 2022

Nov 03, 2022

SELL
$29.63 - $48.31 $103,290 - $168,408
-3,486 Reduced 2.74%
123,876 $4.09 Million
Q2 2022

Aug 11, 2023

SELL
$27.79 - $50.61 $31,097 - $56,632
-1,119 Reduced 0.87%
127,362 $4.48 Million
Q2 2022

Aug 15, 2022

SELL
$27.79 - $50.61 $31,097 - $56,632
-1,119 Reduced 0.87%
127,362 $4.48 Million
Q1 2022

Aug 11, 2023

BUY
$39.62 - $69.97 $255,509 - $451,236
6,449 Added 5.28%
128,481 $5.91 Million
Q1 2022

May 20, 2022

SELL
$39.62 - $69.97 $1.52 Million - $2.69 Million
-38,486 Reduced 23.05%
128,481 $5.91 Million
Q4 2021

Feb 16, 2022

SELL
$58.09 - $82.51 $170,842 - $242,661
-2,941 Reduced 1.73%
166,967 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $68,187 - $99,233
1,168 Added 0.69%
169,908 $10.6 Million
Q2 2021

Aug 12, 2021

SELL
$62.15 - $90.32 $182,285 - $264,908
-2,933 Reduced 1.71%
168,740 $14 Million
Q1 2021

May 03, 2021

SELL
$61.35 - $90.47 $594,849 - $877,197
-9,696 Reduced 5.35%
171,673 $11.4 Million
Q4 2020

Feb 12, 2021

SELL
$43.82 - $85.37 $366,948 - $714,888
-8,374 Reduced 4.41%
181,369 $13.9 Million
Q3 2020

Nov 09, 2020

SELL
$33.21 - $51.27 $137,755 - $212,667
-4,148 Reduced 2.14%
189,743 $8.17 Million
Q2 2020

Aug 10, 2020

SELL
$26.12 - $43.27 $251,326 - $416,343
-9,622 Reduced 4.73%
193,891 $8.26 Million
Q1 2020

May 15, 2020

BUY
$20.56 - $63.12 $200,233 - $614,725
9,739 Added 5.03%
203,513 $5.86 Million
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $3.83 Million - $9.93 Million
136,030 Added 235.57%
193,774 $12.3 Million
Q3 2019

Nov 12, 2019

BUY
$26.26 - $34.86 $1,129 - $1,498
43 Added 0.07%
57,744 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$17.43 - $28.82 $53,858 - $89,053
-3,090 Reduced 5.08%
57,701 $1.53 Million
Q1 2019

May 13, 2019

BUY
$12.05 - $20.18 $96,267 - $161,218
7,989 Added 15.13%
60,791 $1.12 Million
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $37,998 - $69,698
-3,538 Reduced 6.28%
52,802 $656,000
Q3 2018

Nov 14, 2018

SELL
$14.0 - $20.3 $118,272 - $171,494
-8,448 Reduced 13.04%
56,340 $1.08 Million
Q2 2018

Aug 14, 2018

BUY
$6.37 - $14.02 $397,526 - $874,932
62,406 Added 2619.9%
64,788 $881,000
Q1 2018

May 15, 2018

SELL
$3.72 - $7.64 $1,249 - $2,567
-336 Reduced 12.36%
2,382 $17,000
Q4 2017

Feb 08, 2018

BUY
$3.14 - $4.5 $6,546 - $9,382
2,085 Added 329.38%
2,718 $10,000
Q3 2017

Nov 14, 2017

BUY
$1.69 - $4.33 $1,069 - $2,740
633
633 $3,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.